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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of the product BIOSTRONG® 510 (essential oil from thyme and star anise, crushed dried
spices and crushed dried herbs), when used as a feed additive for chickens for fattening and rearing to
point of lay and minor avian species for fattening and rearing to point of lay. BIOSTRONG® 510 is a
preparation of partially microencapsulated essential oils from thyme and star anise, dried herbs and
dried spices. The FEEDAP Panel concludes that BIOSTRONG® 510 is safe for chickens for fattening at
the proposed conditions of use and that this conclusion can be extended to chickens reared for laying
and extrapolated to all minor poultry species for fattening and reared to point of lay. The FEEDAP
Panel concludes that the use of BIOSTRONG® 510 as an additive in the feed for chickens for fattening
does not present risk for the consumer of meat and meat products. Irritancy studies have not been
provided, however, because of the content of saponins, the FEEDAP Panel assumes that the additive is
highly irritant to mucous membranes, and considers that measures to minimise exposure by all routes
are necessary for the handling of this product. The use of BIOSTRONG® 510 at the recommended
levels is not considered to be a risk for the environment. The FEEDAP Panel considers that
BIOSTRONG® 510 has the potential to be efﬁcacious in improving performance of chickens for
fattening. This conclusion can be extended to chickens reared for laying and extrapolated to all minor
poultry species for fattening and reared to point of lay at the same dose.
© 2016 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
Keywords: zootechnical additive, BIOSTRONG® 510, chickens for fattening and reared for laying,
safety, efﬁcacy
Requestor: European Commission
Question number: EFSA-Q-2011-01152
Correspondence: feedap@efsa.europa.eu
EFSA Journal 2016;14(7):4351www.efsa.europa.eu/efsajournal
Panel members: Gabriele Aquilina, Vasileios Bampidis, Maria de Lourdes Bastos, Georges Bories,
Andrew Chesson, Pier Sandro Cocconcelli, Gerhard Flachowsky, J€urgen Gropp, Boris Kolar, Maryline
Kouba, Secundino Lopez Puente, Marta Lopez-Alonso, Alberto Mantovani, Baltasar Mayo, Fernando
Ramos, Guido Rychen, Maria Saarela, Roberto Edoardo Villa, Robert John Wallace and Pieter Wester
Acknowledgements: The Panel wishes to thank the members of the Working Group on Feed
Flavourings including Paul Brantom, Birgit Dusemund, Christer Hogstrand, Anne-Katrine Lundebye,
Derek Renshaw, Patrick Van Beelen and Johannes Westendorf for the support provided to this scientiﬁc
opinion.
Note: This scientiﬁc opinion has been amended following the adoption of the decision of the
Commission on conﬁdentiality claims submitted by the applicant, in accordance with Article 8(6) and
Article 18 of Regulation (EC) No 1831/2003. The abstract has been modiﬁed, as have other sections as
indicated in the text.
Suggested citation: EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used
in Animal Feed), 2016. Scientiﬁc opinion on the safety and efﬁcacy of BIOSTRONG® 510 (essential oil
of thyme and star anise) for chickens and minor avian species for fattening and rearing to point of lay.
EFSA Journal 2016;14(7):4351, 15 pp. doi:10.2903/j.efsa.2016.4351
ISSN: 1831-4732
© 2016 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License,
which permits use and distribution in any medium, provided the original work is properly cited and no
modiﬁcations or adaptations are made.
The EFSA Journal is a publication of the European Food
Safety Authority, an agency of the European Union.
Biostrong® 510 for chickens for fattening and reared for laying
www.efsa.europa.eu/efsajournal 2 EFSA Journal 2016;14(7):4351
Table of contents
Abstract................................................................................................................................................. 1
1. Introduction............................................................................................................................... 4
1.1. Background and Terms of Reference............................................................................................ 4
1.2. Additional information................................................................................................................. 4
2. Data and methodologies ............................................................................................................. 4
2.1. Data.......................................................................................................................................... 4
2.2. Methodologies............................................................................................................................ 5
3. Assessment................................................................................................................................ 5
3.1. Characterisation ......................................................................................................................... 5
3.1.1. Characterisation of the additive ................................................................................................... 5
3.1.2. Characterisation of the active substances ..................................................................................... 6
3.1.3. Manufacturing process of the additive.......................................................................................... 6
3.1.4. Stability and homogeneity........................................................................................................... 6
3.1.5. Physicochemical incompatibilities or interactions ........................................................................... 7
3.1.6. Conditions of use ....................................................................................................................... 7
3.2. Safety ....................................................................................................................................... 7
3.2.1. Safety for the target species ....................................................................................................... 7
3.2.1.1. Conclusions on safety for the target species ................................................................................. 8
3.2.2. Safety for the consumer ............................................................................................................. 8
3.2.2.1. Conclusions on the safety for the consumer ................................................................................. 9
3.2.3. Safety for the user ..................................................................................................................... 9
3.2.3.1. Conclusions on the safety for the user ......................................................................................... 10
3.2.4. Safety for the environment ......................................................................................................... 10
3.3. Efﬁcacy ..................................................................................................................................... 10
3.3.1. Long-term efﬁcacy studies .......................................................................................................... 10
3.3.2. Short-term digestibility studies .................................................................................................... 11
3.3.3. Conclusions on efﬁcacy............................................................................................................... 11
3.4. Post-market monitoring............................................................................................................... 12
4. Conclusions................................................................................................................................ 12
Documentation provided to EFSA ............................................................................................................ 12
References............................................................................................................................................. 12
Abbreviations ......................................................................................................................................... 14
Annex A – Executive Summary of the Evaluation Report of the European Union Reference Laboratory
(EURL) for Feed Additives on the Method(s) of Analysis for BIOSTRONG® 510 ........................................... 15
Biostrong® 510 for chickens for fattening and reared for laying
www.efsa.europa.eu/efsajournal 3 EFSA Journal 2016;14(7):4351
1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from the company Delacon Biotechnik GmbH2 for
authorisation of the product BIOSTRONG® 510 (essential oil from thyme and star anise, crushed dried
spices and crushed dried herbs), when used as a feed additive for chickens for fattening and rearing to
point of lay and minor avian species for fattening and rearing to point of lay (category: zootechnical
additives; functional group: digestibility enhancers, other zootechnical additives).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. According to Article 8 of that Regulation,
EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an
assessment in order to determine whether the feed additive complies with the conditions laid down in
Article 5. The particulars and documents in support of the application were considered valid by EFSA
as of 5 January 2012.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety
for the target animals, consumer, user and the environment and on the efﬁcacy of the product
BIOSTRONG® 510, when used under the proposed conditions of use (see Section 3.1.6).
1.2. Additional information
BIOSTRONG® 510 is an additive consisting of essential oil from thyme and a synthetic mixture
mimicking star anise oil, crushed dried spices and crushed dried herbs. This product has not been
previously authorised in the European Union (EU).
BIOSTRONG® 510 was initially formulated with star anise essential oil. Subsequently, the applicant
replaced the star anise oil with a synthetic mixture to avoid the presence of the known carcinogen
estragole in star anise oil (EC, 2001).
Thymol, the major component in thyme oil, and trans-anethole, the major constituent of star anise
synthetic mixture, have been assessed by the Joint FAO/WHO Expert Committee on Food Additives
(JECFA; WHO, 2000, 2001, 2005a) and were considered safe for use in food. An acceptable daily
intake (ADI) value was set for trans-anethole. The EFSA Panel on Food Additives, Flavourings,
Processing Aids and Materials in Contact with Food (AFC) considered thymol for use as food ﬂavouring
with similar conclusions (EFSA, 2008a). EFSA did not express an opinion on trans-anethole because it
was not included in the evaluation programme (Regulation (EC) No 1565/2000)3. The EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) assessed thymol and trans-
anethole in two opinions and concluded that their use in feed of thymol and trans-anethole is safe up
to 5 and 25 mg/kg feed, respectively (EFSA FEEDAP Panel, 2011a, 2012a).
Thyme oil and star anise oil are included in the EU Register of Feed Additives following the
provisions of Article 10(1) of Regulation (EC) No 1831/2003 as sensory additives, functional group:
ﬂavouring compounds.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of BIOSTRONG® 510 as a feed additive. The
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Delacon Biotechnik GmbH, Weissenwolffstr. 14, 4221, Steyregg, Austria.
3 FEED dossier reference: FAD-2011-0036.
Biostrong® 510 for chickens for fattening and reared for laying
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2016;14(7):4351
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003
and the applicable EFSA guidance documents.
The FEEDAP Panel has sought to use the data provided by the applicant together with data from
other sources, such as previous risk assessments by EFSA or other expert bodies, peer-reviewed
scientiﬁc papers and experts’ knowledge, to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active substance thymol in animal feed. The Executive Summary
of the EURL report can be found in Annex A.4
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of BIOSTRONG®
510 is in line with the principles laid down in Regulation (EC) No 429/20085 and the relevant guidance
documents: Guidance for the preparation of dossiers for zootechnical additives (EFSA FEEDAP
Panel, 2012b), Guidance for the preparation of dossiers for sensory additives (EFSA FEEDAP Panel,
2012c), Technical guidance: Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel,
2011b), Technical Guidance for assessing the safety of feed additives for the environment (EFSA,
2008b), Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel,
2012d), Guidance on studies concerning the safety of use of the additive for users/workers (EFSA
FEEDAP Panel, 2012e).
3. Assessment
3.1. Characterisation
3.1.1. Characterisation of the additive6
BIOSTRONG® 510 is a beige-brownish powder, consisting of the essential oil of thyme and the
mixture of pure compounds mimicking star anise oil (referred to as star anise oil PC), partially
microencapsulated, quillaja bark powder, crushed dried herbs and spices, and other excipients. The
product speciﬁcations are based on the main components. The applicant provides a speciﬁcation for
thymol (2–4 mg/g) and trans-anethole (40–50 mg/g).7 Analysis of ﬁve batches of the additive showed
compliance with these speciﬁcations. Analyses of thymol (mean value 2.92 mg/g, range: 2.9–3.0 mg/g)
and trans-anethole (mean value 45.4 mg/g, range: 44.0–47.5 mg/g)8 showed the minimum
speciﬁcation was exceeded in all cases. Quillaja bark (Quillaja saponaria) contains about 10%
saponins, which consist primarily of glycosides of quillaic acid (quillaja sapogenin, hydroxygypsogenin).
The saponin content in the ﬁnal product is speciﬁed as ≤ 23 mg/g (average in eight batches 20 mg/g,
range: 19–22 mg/g; certiﬁcates of analysis were not provided).
In order to exclude the presence of estragole contained in star anise oil, a mixture of pure
compounds was created containing the major components present in the natural oil in comparable
quantities. This was conﬁrmed by chromatographic analysis. Analysis of ﬁve batches of the star anise
oil PC9 and the reformulated additive10 did not detect estragole (limit of quantiﬁcation (LOQ) < 1 and
< 5 lg/g, respectively).
The applicant routinely monitors the ﬁnal product for impurities, including heavy metals and
arsenic, pesticides and microbial contamination. Data from three batches showed that the levels of
cadmium, lead, arsenic and mercury were between 0.15 and 0.18, 0.70 and 1.00, 1.8 and 2.7 and
< 0.005 and 0.005 mg/kg, respectively, and considered not to be of concern.
Because the additive contains plant materials, a full pesticide residue analysis was made of three
batches. The levels were below the limit of detection (LOD, 0.005–0.01 mg/kg), except for pirimiphos-
4 The full report is available on the EURL website: http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-2011-
0036.pdf
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
6 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
7 Technical Dossier/Supplementary information July 2015.
8 Technical Dossier/Supplementary information July 2015/Annex II.1.3.5.
9 Technical dossier/Supplementary information July 2015/Annex II.1.3.3.
10 Technical dossier/Supplementary information July 2015/Annex II.1.3.4.
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methyl (0.017–0.020 mg/kg) in all three batches and cypermethrin (0.028 mg/kg) in one batch. Total
polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/Fs) were between 0.11
and 0.12 ng WHO-PCDD/F-TEQ (toxic equivalents)/kg. The mycotoxins analysed were zearalenone
< 10 lg/kg, deoxynivalenol 70 lg/kg, ochratoxin A 0.8–1.2 lg/kg and the sum of aﬂatoxins < 2 lg/kg.
These values do not raise safety concerns.
Microbiological quality was addressed with the same three batches of the additive. Salmonella
(colony forming unit (CFU)/25 g) was not detected, Bacillus cereus was between 5 and 20 9 102 CFU/g,
while Staphylococcus aureus, sulﬁte-reducing clostridia, Enterobacteriaceae and Escherichia coli were
< 10 CFU/g.11
Particle size measured by laser diffraction (one batch) ranged from 4.5 to 515 lm. Approximately,
50% of particles exhibited a diameter of 100 lm or less and around 12% of particles had a particle
size diameter smaller than 10 lm.12 Stauber–Heubach data of three batches indicate a high dusting
potential of up to 3.4 g/m3 (range: 3.0–3.4 g/m3).13 The bulk density is 500 kg/m3 8 and the density
is 1,000 kg/m3.12
3.1.2. Characterisation of the active substances6
The active substances in BIOSTRONG® 510 predominantly derive from the thyme oil, star anise oil
PC and quillaja bark. The crushed herbs and spices will also contribute to the activity but to a lesser
extent.
Essential oil of thyme from Thymus vulgaris L. is extracted by steam distillation.14 According to the
European Pharmacopoeia (PhEur), the components identiﬁed in thyme oil are thymol (36–55%),
p-cymene (15–28%), c-terpinene (5–10%), linalool (4–6.5%), carvacrol (1–4%), b-myrcene (1–3%) and
terpinen-4-ol (0.2–2.5%) (PhEur, 2005). The applicant provided the composition of Star Anise oil PC.
The applicant did not provide information on the manufacturing process of quillaja bark powder.
Quillaja bark powder contains about 10% saponins, which consist primarily of glycosides of quillaic
acid (quillaja sapogenin, hydroxygypsogenin). A content of tannins to a maximum of 8% dry matter
has been reported for quillaja bark extracts (WHO, 2005b).
3.1.3. Manufacturing process of the additive6
The applicant provided a detailed description and a ﬂow chart of the manufacturing process of the
additive BIOSTRONG® 510.
3.1.4. Stability and homogeneity
The stability of the additive itself and feed containing the additive was assessed by monitoring the
content of thymol15 and trans-anethole.16
The shelf life of the additive was studied in three batches at 25°C/60% relative humidity (RH) for
18 months and at 40°C/75% RH for 6 months. Losses of around 14–19% for thymol16 and 1–17% for
trans-anethole17 were observed under 25°C and around 27–30% losses of thymol16 in the 40°C/75%
RH conditions.
The stability of BIOSTRONG® 510 was tested in three batches of a vitamin/mineral premixture
containing choline chloride. After 6 months, losses were of about 32–38% for thymol16 and 18–24%
for trans-anethole17 when stored at 25°C, and 38–43% for thymol16 when stored at 40°C.
The stability of BIOSTRONG® 510 in mash feed was tested in three batches. After 4 months, losses
were of about 15–35% for thymol16 and 22–36% for trans-anethole17 when stored at 25°C, and
40–49% for thymol16 when stored at 40°C. In pelleted feed after 4 months, losses were between 24%
and 34% for thymol16 and 1% and 18% for trans-anethole17 at 25°C, and between 31% and 50% for
thymol19 at 40°C. No data were submitted on the effect of feed processing.16,17
11 Technical Dossier/Section II/Annex II.1.4.
12 Technical Dossier/Section II/Annex II.1.5.1.
13 Technical Dossier/Section II/Annex II.1.5.2.
14 Technical Dossier/Section II/Identity.
15 Technical Dossier/Section II/Annex II.4.1.2.
16 Technical Dossier/Supplementary information May 2012/Annex II.4.1.3.
17 Technical Dossier/Section II/Annex II.4.2.
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These data indicate that the concentration of the compounds thymol and trans-anethole decreases
with time in the additive, premixtures, mash and pelleted feed.
The homogeneous distribution of the additive in a premixture and a complete feedingstuff was
assessed by measuring the thymol content in 10 subsamples each of a premixture and a mash and
pelleted feed.17 The coefﬁcients of variation were 4.4% in premixtures, 4.8% in mash feed and 2.8%
in pelleted feed.
3.1.5. Physicochemical incompatibilities or interactions
Based on current knowledge, no incompatibilities resulting from the use of the product in compound
feed are expected with other feed materials, carriers, other approved additives or medicinal products.
3.1.6. Conditions of use
BIOSTRONG® 510 is intended for use in feed for chickens for fattening, chickens reared for laying
and minor species for fattening and reared to point of lay at a dose of 150 mg/kg complete
feedingstuffs.
3.2. Safety
All of the studies related to safety were made with the original formulation containing natural star
anise oil. Given the degree of similarity of the mixture (star anise oil PC) and the natural oil, the
FEEDAP Panel considers that the safety studies made with the original formulation can be used to
assess the safety of the new formulation.
3.2.1. Safety for the target species
Two tolerance studies in chickens for fattening with BIOSTRONG® 510 were provided.
In the ﬁrst study, 576 1-day-old male Cobb 500 chickens were distributed into 24 pens and
allocated to one of four dietary treatments, resulting in six replicates of 24 chickens per treatment.18
Feed and water were available ad libitum over an experimental period of 42 days. The starter diet
(pelleted feed) was offered from day 1 until day 21 and the ﬁnisher diet (pelleted feed) from day 22
until day 42 of the experiment. BIOSTRONG® 510 was incorporated into a basal maize–wheat–
soybean meal at 0, 150 (9 1 recommended dose), 750 (9 5) and 1,500 (9 10) mg/kg of feed.
Conﬁrmation of the dose was made by analysis of the thymol content of the feed (0.01, 0.45, 1.90
and 4.16 mg/kg thymol, respectively, for the starter feed). Mortality and zootechnical performance
(average daily feed intake, body weight, average daily gain and feed to gain ratio) were recorded. In
addition, routine blood haematology and biochemistry were carried out, at 35 days of age, on 12 birds
per treatment (two per pen).19 At 42 days of age, 12 birds per treatment (the same that had been
selected for blood analysis) were killed for gross pathology examination. An analysis of variance
(ANOVA) was performed with the data considering the pen as the experimental unit. Differences were
considered signiﬁcant at a level of at least p < 0.05.
The birds remained healthy throughout the study. The overall mortality rate was low (1.04%).
Inclusion of BIOSTRONG® 510 at any dose tested did not signiﬁcantly affect average daily feed intake
(101–106 g/day), ﬁnal body weight (2.9–3.0 kg) and average daily gain (69.2–71.3 g/day). A dose-
dependent improvement (p < 0.001) of feed to gain ratio (1.53, 1.48, 1.44 and 1.42 for the
treatments of 0, 150, 750 and 1,500 mg BIOSTRONG® 510/kg feed, respectively) was recorded for
the overall experimental period. Blood haematology and biochemistry (35th day of age), and gross
pathology at post-mortem (42nd day of age) examination, did not reveal any sign of toxicity.
In a second study, 432 1-day-old male and female Ross 308 chickens were distributed into 36 pens
and allocated to one of three dietary treatments, resulting in 12 replicates of 12 chickens per
treatment (equal distribution of male and female chickens).20 Feed and water were available ad libitum
over an experimental period of 35 days. The starter diet (mash feed) was offered from day 1 until day
14, the grower diet (mash feed) was offered from day 15 until day 28 and the ﬁnisher diet (mash
18 Technical Dossier/Section III/Annex III.1.2.Conf.
19 White and red blood cells, lymphocytes, haemoglobin, haematocrit, mean corpuscular volume (MCV), mean corpuscular
haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), electrolytes (sodium, potassium, chloride, calcium
and phosphorus), alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total cholesterol, triglycerides,
uric acid, bilirubin, glucose, total protein and albumin.
20 Technical Dossier/Section III/Annex III.1.1.Conf.
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feed) from day 29 until day 35 of the experiment. BIOSTRONG® 510 was incorporated into a basal
maize–wheat–soybean meal at 0, 150 (9 1 recommended dose, 0.29, 0.28 and 0.27 mg/kg thymol,
analysed for starter, grower and ﬁnisher diets, respectively) and 1,500 (9 10, 3.00, 2.54 and 2.87 mg/kg
thymol, analysed for starter, grower and ﬁnisher diets, respectively) mg/kg. The analysed thymol
content was lower by 50% compared to the theoretical thymol content. Mortality and zootechnical
performance (average daily feed intake, body weight, average daily gain and feed to gain ratio) were
recorded. At 35 days of age, 72 chickens (24 from each treatment group, gender not speciﬁed) were
killed and the carcass characteristics evaluated. In addition, meat and liver samples of six chickens per
treatment (3 males and 3 females) were taken in order to analyse possible residues of thymol (meat),
trans-anethole (meat) and a-pinene (meat and liver).21 An ANOVA was made with the performance
data considering the pen as the experimental unit, except for the residue analysis where individual
chicken was the experimental unit. Differences were considered signiﬁcant at a level of at least
p < 0.05.
The overall mortality rate was low (2.8%). Inclusion of BIOSTRONG® 510 at any dose tested did
not signiﬁcantly affect average daily feed intake (94.0–96.7 g/day), ﬁnal body weight (2.1–2.2 kg),
average daily gain (60.6–60.9 g/day) and feed to gain ratio (1.56–1.59). Carcass composition data at
slaughter did not reveal negative effects of BIOSTRONG® 510 on carcass quality. Thymol, trans-
anethole and a-pinene were not detected in meat samples (respective LODs: 0.01, 0.1 and 0.1 lg/g
thymol, trans-anethole and a-pinene) and a-pinene was not detectable in liver samples (LOD: 0.1 lg/g
liver).22
3.2.1.1. Conclusions on safety for the target species
Chickens for fattening tolerated a 10-fold overdose of BIOSTRONG® 510, as shown in the tolerance
study, without any adverse effects on health, performance or blood parameters. This is supported by
the observation of another trial in which no adverse effects on performance parameters were
observed.
Therefore, the FEEDAP Panel concludes that BIOSTRONG® 510 is safe for chickens for fattening at
the proposed dose of 150 mg/kg complete feedingstuffs. The FEEDAP Panel considers that this
conclusion can be extended to chickens reared for laying and extrapolated to all minor poultry species
for fattening or reared to point of lay at the same dose.
3.2.2. Safety for the consumer
The assessment of the consumer safety is based on reported composition of the ingredients of the
additive.
• Thyme oil and star anise oil6
Thymol and trans-anethole, the two major constituents of thyme oil and star anise oil PC, are
currently authorised for use in food without limitations.
Thymol [FLAVIS-no: 04.006] has been evaluated by JECFA (WHO, 2004a) and EFSA (EFSA, 2008b) as
food ﬂavour. The FEEDAP Panel considered that the use of thymol as ﬂavour in all animal species up to
the highest use level proposed in feed (5 mg/kg) is safe for the consumer (EFSA FEEDAP Panel, 2012a).
trans-Anethole [04.010] has been evaluated by JECFA (WHO, 2000) that established an ADI of
0–2 mg/kg body weight (bw) per day. This ADI was based on a 90-day study in rats showing
alteration in serum parameters considered to be indicative of hepatotoxicity and a safety factor of 200,
taking into account the deﬁciencies of the studies considered. In its opinion on trans-anethole as a
feed ﬂavouring for all animal species, the FEEDAP Panel considered that its use up to the highest use
level proposed in feed (25 mg/kg) is safe for the consumer (EFSA FEEDAP Panel, 2011a).
The maximum declared values of thymol (4 mg/g) and trans-anethole (50 mg/g) content in the
additive were considered in the assessment. The use of BIOSTRONG® 510 at a level of 150 mg/kg
feed will result in a maximum content of 0.6 mg thymol/kg and 7.5 mg trans-anethole/kg in complete
feed. These levels are lower than the feed concentrations considered safe for consumers (EFSA
FEEDAP Panel, 2011a, 2012a).
21 Technical Dossier/Section III/Annex III.1.1.Conf. and Supplementary information May 2012/Annex III.1.3. and Supplementary
information May 2013/Annex III.2.1.2.
22 Technical Dossier/Section III/Annex III.1.1.Conf. and Supplementary information May 2012/Annex.III.1.3.
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Analyses of meat and liver samples from six chickens fed BIOSTRONG® 510 for 5 weeks at the
maximum recommended dose (150 mg/kg feed) and 10-fold the maximum dosage (1,500 mg/kg
feed) did not detect any thymol or trans-anethole residues (see second tolerance study).22
The concentrations of the other components in feed supplemented with 150 mg BIOSTRONG®
510/kg were calculated considering the maximum value of the concentration range reported in
Section 3.1.2. The resulting concentrations were compared with the ones considered as safe in
previous assessments of the individual substances used as feed ﬂavourings in feed for poultry (EFSA
FEEDAP Panel, 2012a,f,g, 2015, 2016). Linalool is present in both thymol and star anise oil; therefore,
the concentrations were summed up.
cis-Anethole have not been previously assessed by EFSA. The FEEDAP Panel noted that a no
adverse effect level of 172 mg/kg per day was derived from a chronic study in rat (Truhaut et al.,
1989).23 However, the Panel did not have access to this study and concluded on a safe level using the
threshold of toxicological concern (TTC) approach.
For all compounds the levels in feed supplemented with BIOSTRONG® 510 at 150 mg/kg are
considerably lower than the feed concentrations which were considered safe for consumers.
• Quillaja bark powder
Quillaja bark (Quillaja saponaria) contains about 10% saponins, which consist primarily of
glycosides of quillaic acid (quillaja sapogenin, hydroxygypsogenin). Saponins are strongly irritating to
mucous membranes and can cause haemolysis and tissue damage after absorption (Westendorf,
1999). Small quantities of quillaja bark extracts (up to 200 mg/kg) are added as foaming agents to
carbonated beverages and other foodstuffs (WHO, 2005b) and for pharmaceutical purposes as an
absorption enhancer of drugs (Recchia et al., 1995). No adverse effects were observed in a study on
human volunteers orally administered a drink containing 0.5 mg quillaja saponins/kg bw per day for
7 days (Naknukool et al., 2011). An ADI of 1 mg kg/bw was established by the Australian Food
Standard Agency for quillaja extract (2013).
Considering the quantity fed to chickens (0.36 mg saponins/day) and the poor absorption of
saponins in the gastrointestinal tract (Cheeke, 1989), and the fact that it will not be deposited in tissue
and that no residues are expected, neither there will be an exposure of consumers, toxic effects of
quillaja saponins are not expected to occur after consumption of food prepared from animals receiving
feed containing the additive.
• Crushed dried herbs and spices6
Most of the herbs and spices are consumed by humans in appreciable quantities and, their safety
does not need further assessment, except for some that the Panel assessed.
3.2.2.1. Conclusions on the safety for the consumer
Considering the composition of BIOSTRONG® 510, the consumer exposure to any possible residues
of the components of essential oils, quillaja bark, and the herbs and spices would be within the range
of exposures considered safe for food use. The FEEDAP Panel, therefore, concludes that the use of
BIOSTRONG® 510 as an additive in the feed for target animals would not measurably increase the
exposure of consumers and, therefore, would not present a risk for the consumer.
3.2.3. Safety for the user6
• Effects on skin and eyes
No data on effects of BIOSTRONG® 510 on skin and eyes were provided by the applicant. The
additive contains compounds with the potential to irritate mucous membranes (saponins from quillaja
bark). Moreover, essential oils and crushed dried herbs present in BIOSTRONG® 510 may induce
allergies in sensitive persons, handling the additive as recognised by the applicant in the Material
Safety Data Sheet (MSDS).24 Therefore, the FEEDAP Panel considers BIOSTRONG® 510 as an irritant
to skin and eyes and as a skin sensitiser.
23 Chronic study (2 years) in rat; dose: 0, 0.25, 0.5, 1% [c], conversions were calculated using standard values.
24 Technical Dossier/Supplementary information July 2015/Annex II.5.2.1_updated.
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• Effects on respiratory system
Exposure of the respiratory system of users handling BIOSTRONG® 510 can occur by inhalation of
volatile components as well as dust of the additive. Data on particle size indicate that approximately
50% of the particles have a diameter below 100 lm and approximately 12% below 10 lm. The
dusting potential of the additive according to Stauber–Heubach is up to 3.4 g/m3, which suggest a
high possibility of exposure during handling. Thus, it is likely that the respiratory tract of users is
exposed to the dust. The additive contains components with a potential to irritate mucous membranes
of the respiratory tract and to cause inﬂammation of lung tissue (saponins, silicon dioxide).
BIOSTRONG® 510 also contains a variety of components with the potential to induce allergic reactions
(dried crushed herbs, essential oils). This assumption is conﬁrmed by experience of the applicant, who
classiﬁes BIOSTRONG® 510 as a respiratory sensitiser on the basis of manufacturing experience.
3.2.3.1. Conclusions on the safety for the user
BIOSTRONG® 510 is considered as irritating to skin, eyes and the respiratory system, and as a
potential skin and respiratory sensitiser.
3.2.4. Safety for the environment6
The additive contains compounds naturally present in the environment that will not result in a
substantial increase in their concentration in the environment at the application rate of 150 mg
BIOSTRONG® 510/kg feed for chickens for fattening. An environmental risk assessment of the major
(thymol and trans-anethole) and other components of essential oils (linalool, p-cymene, c-terpinene,
carvacrol, b-myrcene, terpinen-4-ol, a-terpineol and anisaldehyde) showed no risk for the environment
at the concentrations which were considered safe for targets species. The maximum concentration of
saponins in BIOSTRONG® 510 results in 3.3 mg/kg feed. The corresponding predicted environmental
concentrations in soil would be 17 lg saponin/kg when calculated for chickens for fattening according
to the EFSA guidance (EFSA, 2008a). This low predicted environmental concentration can easily be
surpassed by the growth of soapwort (Saponaria ofﬁcinalis). Therefore, the use of BIOSTRONG® 510
at the recommended levels is not considered to be a risk for the environment.
3.3. Efﬁcacy
The FEEDAP Panel considers that the studies made with the original formulation can be used to
assess the efﬁcacy of the new formulation.
The applicant submitted ﬁve long-term feeding studies supported by six short-term digestibility
studies to demonstrate the efﬁcacy of the additive in chickens for fattening. The mortality registered in
one of the long-term studies25 was high (14% on average) and, therefore, this study was not further
considered in the assessment.
3.3.1. Long-term efﬁcacy studies
Details on the design and the results of the four long-term studies26 considered are presented in
Table 3. Chickens were fed the experimental diets for 42 days in three studies and 35 days in another
study. Trials 1, 2 and 3 were carried out as a 2 9 2 design, with two basal diets that differed in the
nutrient and energy content and two levels of additive supplementation (non-supplemented vs
supplementation at the recommended dose of 150 mg/kg feed). In the remaining trial (trial 4), two
experimental diets were considered, a control diet and the control diet supplemented with the additive
at the recommended dose. The basal diets (starter and grower) were based on maize, wheat and soya
bean meal (in trial 1 wheat was not included) and were offered ad libitum in mash (studies 1, 2 and 3)
or pelleted form (study 4). Conﬁrmation of dose was obtained from the analysed thymol content of the
diet. General conditions of the animals and mortality were checked/recorded. Feed intake and body
weight were measured throughout the experimental period. Feed to gain ratio was calculated. In each
study, an ANOVA was performed with the data considering the pen as the experimental unit.
Differences were considered signiﬁcant at a level of at least p < 0.05.
25 Technical Dossier/Section IV/Annex IV.3.6. Conf.
26 Technical Dossier/Section IV/Annex IV.3.7.Conf., Annex IV.3.8.Conf., Annex IV.3.9.Conf. and Annex IV.3.10.Conf.
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Mortality did not signiﬁcantly differ between the groups in each study. The statistical analysis of the
three studies, which included two dietary formulations, showed no interaction between the two main
factors (type of diet and the addition of the additive). Therefore, only the results of the additive
supplementation are presented. The supplementation of the diets with the additive resulted in a better
feed to gain ratio in three studies (studies 1, 3 and 4) and in a better daily weight gain in one study
(study 2).
The applicant submitted a meta-analysis27 of the long-term studies. However, this included the
study discounted on the ground of high mortality and, therefore, the results of the meta-analysis are
not considered.
3.3.2. Short-term digestibility studies
Six short-term efﬁcacy and digestibility studies have been performed in two different locations.28 All
studies shared a common design in which an equal number of male broilers were allocated to two
treatments, a control, receiving a basal maize–soybean mean diet and the treated group, receiving the
basal diet supplemented with BIOSTRONG® 510 at 150 mg/kg feed. Birds were fed ad libitum for
21 days. The diets contained an indigestible marker (titanium dioxide at 3 g/kg or chromium (III)
oxide at 5 g/kg). Zootechnical performance (mortality, average daily feed intake, body weight, average
daily gain and feed to gain ratio) was recorded for the experimental period of 1–21 days of age. At
21 days of age, all birds were killed and the ileum contents collected for analysis.
The addition of BIOSTRONG® 510 resulted in a signiﬁcant improvement of digestibility of dry
matter (1/6 studies), organic matter (3/6 studies), crude protein (4/6 studies) and crude fat (2/6
studies). Mortality and performance of chickens over the 21-day experimental period were as
expected.
3.3.3. Conclusions on efﬁcacy
BIOSTRONG® 510 has the potential to improve the performance of chickens for fattening by
improving the feed to gain ratio or weight gain at a dose of 150 mg/kg complete feed. The results of
the digestibility studies which indicated improved ileal digestibility is consistent with the effects seen in
the long-term efﬁcacy studies.
Table 3: Effect of BIOSTRONG® 510 (150 mg/kg diet) on mortality and performance of chickens
for fattening in four long-term studies
Study
(Sex, breed)
Animals per
replicate
Replicates per
treatment
Duration
of the
study
(days)
BIOSTRONG®
510 (mg/kg
feed)
Feed
intake
(g/day)
Final
body
weight
(g)
Weight
gain
(g/day)
Feed to
gain
Mortality
(%)
1(b) (♂, Ross 308)
30
35 0 90.5 1,689 47.1 1.92 7.1
7 150 89.7 1,726 48.1 1.86(a) 5.2
2 (♂,♀; Ross 308)
22
42 0 111 2,417 56.5 1.96 6.8
12 150 110 2,453 57.4 1.92 7.8
3 (♂, Cobb 500)
20
42 0 91.3 2,718 63.8 1.43 1.2
6 150 88.9 2,744 64.4 1.38(a) 0.8
4 (♂, Cobb 500)
24
42 0 106.1 2,946 69.2 1.53 0.7
6 150 103.9 2,997 70.4 1.48(a) 1.4
(a): Means of the treated group and controls within the same study are signiﬁcantly different (p < 0.05).
(b): Technical Dossier/Section IV/Annex IV.3.7.Conf.
27 Technical Dossier/ Section IV/Annex IV. 3.12.Conf.
28 Technical Dossier/ Section IV/Annex IV. 3.1.Conf., Annex IV. 3.2.Conf., Annex IV. 3.3.Conf., Annex IV. 3.4.Conf., Annex IV.
3.5.Conf., and Annex IV. 3.10.Conf.
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The FEEDAP Panel considers that these conclusions can be extended to chickens reared for laying
and extrapolated to all minor poultry species for fattening or reared to point of lay at the same dose.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation29 and Good
Manufacturing Practice.
4. Conclusions
The FEEDAP Panel concludes that BIOSTRONG® 510 is safe for chickens for fattening at the
proposed dose of 150 mg/kg complete feed. The Panel considers that this conclusion can be extended
to chickens reared for laying and extrapolated to all minor poultry species for fattening and reared to
point of lay.
The FEEDAP Panel concludes that the use of BIOSTRONG® 510 as an additive in the feed for target
species does not present risk for the consumer.
BIOSTRONG® 510 is considered as irritating to skin, eyes and the respiratory system, and as a
potential skin and respiratory sensitiser.
The use of BIOSTRONG® 510 at the recommended dose is not considered to be a risk for the
environment.
BIOSTRONG® 510 has the potential to improve the performance of chickens for fattening by
improving the feed to gain ratio at a dose of 150 mg/kg complete feed. The FEEDAP Panel considers
that this conclusion can be extended to chickens reared for laying and extrapolated to all minor poultry
species for fattening and reared to point of lay at the same dose.
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Abbreviations
ADI acceptable daily intake
AFC EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact
with Food
ANOVA analysis of variance
bw body weight
CEF Panel EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CFU colony forming unit
EURL European Union Reference Laboratory
FAO Food Agricultural Organization
FEEDAP Panel EFSA Panel on Additives and Products or Substances used in Animal Feed
FGE food group evaluation
FLAVIS The EU Flavour Information System
FL-no FLAVIS number
GC–MS gas chromatography–mass spectrometry
LOD limit of detection
LOQ limit of quantiﬁcation
MCH mean corpuscular haemoglobin
MCV mean corpuscular volume
MCHC mean corpuscular haemoglobin concentration
MSDS Material Safety Data Sheet
PCDD polychlorinated dibenzo-p-dioxin
PCDD/F polychlorinated dibenzofuran
PhEur European Pharmacopoeia
Rrec recovery rate
RH relative humidity
RSDr standard deviation for repeatability
RSDip standard deviation for intermediate precision
TTC threshold of toxicological concern
WHO World Health Organization
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory (EURL) for Feed Additives on the Method(s) of
Analysis for BIOSTRONG® 510
In the current application, authorisation is sought under Article 4(1) for BIOSTRONG® 510 under
the category/functional group 4(a)&(d) ‘zootechnical additives/digestibility enhancers & other
zootechnical additives’ according to Annex I of Regulation (EC) No 1831/2003. Authorisation is sought
for the use of the feed additive for chickens and minor avian for fattening or rearing to point of lay.
BIOSTRONG® 510 is a preparation of partially microencapsulated essential oils of thyme and star
anise, with a guaranteed minimum content of the active substance (Thymol) of 2 g/kg in an excipient
based on mixed dried herbs and spices, and other bulking and anticaking agents. The feed additive is
intended to be incorporated in complete or complementary feedingstuffs through premixtures. The
Applicant proposed a dosage of 150 mg BIOSTRONG® 510/kg feedingstuffs, which corresponds to
0.3 mg/kg of Thymol in feedingstuffs.
For the determination of Thymol in the feed additive, premixtures and feedingstuffs, the Applicant
proposed a single-laboratory validated and further veriﬁed method based on gas chromatography–
mass spectrometry (GC–MS). The following performance characteristics were reported:
 a standard deviation for repeatability (RSDr) and for intermediate precision (RSDip) ranging
from 1.4 to 9.2%;
 a recovery rate (Rrec) ranging from 98.3 to 119%;
 a limit of quantiﬁcation (LOQ) of 21 µg/kg.
Based on these performance characteristics, the EURL recommends for ofﬁcial control the single-
laboratory validated and further veriﬁed method based on gas chromatography–mass spectrometry
(GC–MS) for the determination of Thymol in the feed additive, premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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